Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1194)
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
228
Price
$18.36
Total Value
$4.19K
Shares Held After
154,353
% of Holdings
0.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,728
Price
$3.61
Total Value
$9.84K
Shares Held After
1,043,327
% of Holdings
0.3%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
3,361
Price
$3.61
Total Value
$12.12K
Shares Held After
678,639
% of Holdings
0.5%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
100,000
Price
$1.19
Total Value
$119.00K
Shares Held After
222,497
% of Holdings
44.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
14,056
Price
$28.58
Total Value
$401.79K
Shares Held After
63,443
% of Holdings
18.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
600
Price
$70.81
Total Value
$42.49K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,950
Price
$69.79
Total Value
$275.66K
Shares Held After
768,380
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,350
Price
$68.88
Total Value
$230.75K
Shares Held After
772,330
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,100
Price
$68.10
Total Value
$143.01K
Shares Held After
775,680
% of Holdings
0.3%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
44,679
Price
$0.54
Total Value
$24.13K
Shares Held After
1,126,496
% of Holdings
3.8%
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
37,453
Price
$5.36
Total Value
$200.75K
Shares Held After
232,308
% of Holdings
16.1%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,298
Price
$5.28
Total Value
$17.41K
Shares Held After
185,150
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
459
Price
$224.00
Total Value
$102.82K
Shares Held After
41,786
% of Holdings
1.1%
Shattuck Labs, Inc. (STTK)
Shukla Abhinav A. — Chief Technical Officer
Shares
2,032
Price
$7.01
Total Value
$14.24K
Shares Held After
81,258
% of Holdings
2.4%
Shattuck Labs, Inc. (STTK)
Pandite Arundathy N. — Chief Medical Officer
Shares
30,000
Price
$6.61
Total Value
$198.30K
Shares Held After
166,219
% of Holdings
15.3%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Lu Hongbo — Director
Shares
2,970
Price
$76.88
Total Value
$228.33K
Shares Held After
52,012
% of Holdings
5.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,500
Price
$67.98
Total Value
$101.97K
Shares Held After
486,500
% of Holdings
0.3%
Lantern Pharma Inc. (LTRN)
KEYSER D JEFFREY — Director
Shares
48,544
Price
$2.06
Total Value
$100.00K
Shares Held After
94,303
% of Holdings
51.5%
Lantern Pharma Inc. (LTRN)
Schalop Lee Troy — Director
Shares
48,544
Price
$2.06
Total Value
$100.00K
Shares Held After
48,544
% of Holdings
100.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
6,988
Price
$450.00
Total Value
$3.14M
Shares Held After
26,088
% of Holdings
21.1%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
12,500
Price
$8.01
Total Value
$100.12K
Shares Held After
513,884
% of Holdings
2.4%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
800
Price
$13.83
Total Value
$11.06K
Shares Held After
830,584
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$29.36
Total Value
$186.35K
Shares Held After
69,792
% of Holdings
8.3%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
16,940
Price
$3.29
Total Value
$55.73K
Shares Held After
808,008
% of Holdings
2.1%
MANNKIND CORP (MNKD)
Thomson David — EVP Genl Counsel & Secretary
Shares
3,033
Price
$3.29
Total Value
$9.98K
Shares Held After
826,299
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,800
Price
$73.12
Total Value
$204.74K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,900
Price
$72.15
Total Value
$425.67K
Shares Held After
770,580
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,802
Price
$71.37
Total Value
$699.57K
Shares Held After
776,480
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,398
Price
$70.29
Total Value
$98.26K
Shares Held After
786,282
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
100
Price
$67.85
Total Value
$6.78K
Shares Held After
787,680
% of Holdings
0.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
73,296
Price
$6.20
Total Value
$454.44K
Shares Held After
103,417
% of Holdings
41.5%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
16,961
Price
$4.29
Total Value
$72.82K
Shares Held After
176,293
% of Holdings
8.8%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,322
Price
$26.71
Total Value
$88.73K
Shares Held After
466,375
% of Holdings
0.7%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
4,281
Price
$37.09
Total Value
$158.77K
Shares Held After
216,744
% of Holdings
1.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
14,219
Price
$36.64
Total Value
$520.98K
Shares Held After
221,025
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
258
Price
$581.93
Total Value
$150.14K
Shares Held After
5,028
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
56
Price
$583.44
Total Value
$32.67K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,464
Price
$582.80
Total Value
$853.22K
Shares Held After
40,569
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
982
Price
$581.62
Total Value
$571.15K
Shares Held After
42,033
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,706
Price
$580.62
Total Value
$990.53K
Shares Held After
43,015
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
492
Price
$579.67
Total Value
$285.20K
Shares Held After
44,721
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
778
Price
$578.46
Total Value
$450.04K
Shares Held After
45,213
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,062
Price
$577.44
Total Value
$613.24K
Shares Held After
45,991
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
767
Price
$576.23
Total Value
$441.97K
Shares Held After
47,053
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
753
Price
$575.47
Total Value
$433.33K
Shares Held After
47,820
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$573.70
Total Value
$230.05K
Shares Held After
48,573
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
293
Price
$573.12
Total Value
$167.92K
Shares Held After
48,974
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$571.71
Total Value
$60.60K
Shares Held After
49,267
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$570.31
Total Value
$228.13K
Shares Held After
49,373
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$568.83
Total Value
$136.52K
Shares Held After
49,773
% of Holdings
0.5%
Showing 351–400 of 1194 transactions (page 8 of 24)